Universal Health Services, Inc.

UHS Healthcare Medical - Care Facilities NYSE

$231.08

+$0.49 (+0.21%)

Open: $232.87 | High: $232.87 | Low: $229.60 | Prev Close: $230.59

Market Cap: $14.90B

Volume: 322K | Avg: 663K

Last updated: December 05, 2025 at 10:07 PM
Investment Rating
A-

Buy

Overall Score: 80/100


Rating Breakdown:
DCF Score 4/5
80%
Buy
ROE Score 5/5
100%
Strong Buy
ROA Score 5/5
100%
Strong Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 3/5
60%
Neutral
P/B Score 3/5
60%
Neutral

Stock Score Analysis
D

Stock Score: 590

Comprehensive Quality Assessment


Component Breakdown:
Efficiency 35
Financial Health 40
Growth 70
Market Sentiment 20
Risk 40
Lower is better
Valuation 50
Momentum 35

Valuation Metrics
Valuation Ratios
P/E Ratio 11.00
P/B Ratio 2.06
P/S Ratio 0.88
EPS $21.01
Beta 1.29
Shares Outstanding 64.47M

Price Range & Moving Averages
52-Week High $246.33
52-Week Low $152.33
SMA 50 $217.95
SMA 200 $188.93

Dividend Information
Dividend Yield 0.35%
Annual Dividend $0.80

Earnings
Next Earnings February 25, 2026 05:00 AM ET
Financial Ratios
Margins
Gross Margin 90.3%
Operating Margin 11.5%
Net Margin 8.1%

Returns
ROE 19.9%
ROA 9.0%

Liquidity & Leverage
Debt/Equity 0.71
Current Ratio 1.03
Quick Ratio 0.96
Balance Sheet
Total Assets $14.47B
Total Liabilities $7.71B
Total Equity $6.67B

Cash $125.98M
Total Debt $4.96B
Net Debt $4.83B
Income Statement
Revenue $15.83B
Gross Profit $14.24B
Operating Income $1.68B
Net Income $1.14B

EBITDA $2.27B
Revenue/Share $264.04
Cash Flow
Operating CF $2.07B
CapEx $943.81M
Free Cash Flow $1.12B

Book Value/Share $113.39
Tangible Book/Share $51.40
Equity/Share $112.35
Technical Indicators
RSI (14) 53.51 Neutral
MACD
5.52 Signal: 6.55
Volatility 27.62%
Trading Signal Bearish
Performance & Returns
Total Returns
1 Year +25.98%

Risk-Adjusted Returns
Sharpe Ratio 0.87 Fair
Volatility (Ann.) 34.73% Moderate

vs S&P 500 (SPY)
UHS (1Y) +25.98%
S&P 500 (1Y) +11.86%
Alpha (Excess Return) +14.12%
Sector Comparison (Healthcare)
Compared to 59 peers in Healthcare
Metric UHS Sector Avg Percentile
P/E Ratio 11 31.55 12%
P/B Ratio 2.06 -0.59 33%
ROE (%) 19.85% 9.63% 65%
Net Margin (%) 8.09% 10.08% 35%
Stock Score 590 503.0 92%
1Y Return (%) +25.98% +4.05% 83%
Percentile: 0% = worst in sector, 100% = best in sector
Historical Price Analysis (Last 200 Days)
Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
UHS $231.08 $236.50 $238.42 $234.46 $217.95 $188.93 53.51 5.52 27.62% 475638 Weak Short Price Below SMAs
Candlestick Patterns

There wasn't any recognizable pattern for the UHS stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
UHS UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services's Directors and Officers for Breach of Fiduciary Duties – UHS Neutral businesswire.com Read More
UHS KMT, UHS, and More Are Now Strong Buy Stocks (Dec. 3) Neutral zacks.com Read More
UHS Best Growth Stocks to Buy for Dec.3 Positive zacks.com Read More
UHS Best Value Stocks to Buy for Dec. 3 Neutral zacks.com Read More
UHS Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term Neutral zacks.com Read More
Company Information

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.


CEO Marc D. Miller
Employees 99300
Country US
IPO Date 1981-07-09
Exchange NYSE
Website https://uhs.com
Sector Healthcare
Industry Medical - Care Facilities
Similar Stocks (Healthcare - Medical - Care Facilities)
HCA

HCA Healthcare, Inc.

Price: $486.70
Change: -0.20%
Market Cap: $1181B
P/E: 18.83
Score: D (530)
View Details
SOLV

Solventum Corporation

Price: $85.43
Change: +0.20%
Market Cap: $1481B
P/E: 9.81
Score: E (330)
View Details
DVA

DaVita Inc.

Price: $117.39
Change: +0.09%
Market Cap: $8287B
P/E: 12.13
Score: E (500)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.


Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.